Lessee, Operating Lease, Liability, to be Paid, Year One of Protalix BioTherapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Protalix BioTherapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
Protalix BioTherapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Sep 2025 was $1,397,000.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,397,000			30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q4 2024	$1,500,000	+$91,000	+6.5%	31 Dec 2024	10-K	17 Mar 2025	2024	FY
Q4 2023	$1,409,000	+$291,000	+26%	31 Dec 2023	10-K	14 Mar 2024	2023	FY
Q4 2022	$1,118,000	-$89,000	-7.4%	31 Dec 2022	10-K	27 Feb 2023	2022	FY
Q4 2021	$1,207,000	-$26,000	-2.1%	31 Dec 2021	10-K	31 Mar 2022	2021	FY
Q4 2020	$1,233,000			31 Dec 2020	10-K	30 Mar 2021	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.